News

Photo of glowing, pink diamond-shaped figure. This is illuminated with light, encircled with a wreath of around 70 blue tube-like shapes.
Promethium’s secrets exposed
Male student wearing clear safety goggles peering through a 3D-printed item.
tnAchieves students learn about lab careers
Photo of a man in a black jacket suit with a blue shirt crossing his arms outside. He is smiling.
Wagner receives ASME Medal

Filter News

Area of Research

News Type

Date

News Topics

Media Contacts

Connect with ORNL

Ashleigh Kimberlin and Mikayla Molnar achieve success with a gas-trapping apparatus for Ac-225 production. Credit: ORNL, U.S. Dept. of Energy

Tri-Lab effort makes strides toward increasing supply of Ac-225

In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.

The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.

Five ORNL scientists to receive DOE Early Career Research awards

The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.

Neutron scattering experiments show electric charges, shown in red, blue and grey, in the SARS-CoV-2 main protease site where telaprevir binds to the structure. The experiments provide critical data for the design of small-molecule drugs to treat COVID-19. Credit: Jill Hemman and Michelle Lehman/ORNL, U.S. Dept. of Energy

Neutrons reveal unpredicted binding between SARS-CoV-2, hepatitis C antiviral drug

Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.